The potential benefits and risks of developing "mirror life"
1Description
Synthetic biologists are hard at work developing artificial biological molecules as the first step toward developing a mirror cell that would be immune from infection. If they're successful, it could transform the world of medicine. But while the potential of mirror life is great, so too are the risks. There are warnings of a catastrophic impact if the cells can't be controlled. And that's prompted calls for a moratorium on the research.
Guests
Associate Professor Kate Adamala — Synthetic biologist and professor of genetics, University of Minnesota
Professor Andrew Ellington — Center for Systems and Synthetic Biology, University of Texas at Austin
Professor Heather Douglas — Department of Philosophy, Michigan State University
Ajay Kshatriya — CEO Aizen Therapeutics
United States
